CNTG - Centogene Takeda extend diagnostic partnership
2024-03-19 07:41:32 ET
More on Centogene, Takeda, etc.
- Takeda Pharmaceutical: Eohilia's FDA Approval Brings Tailwinds
- Takeda Pharmaceutical Company: Attractive Stock But Needs To Grow Net Profits
- Takeda Pharmaceutical Company Limited 2023 Q3 - Results - Earnings Call Presentation
- Takeda buoyed by mid-stage trial for immune disorder treatment mezagitamab
- Pfizer succeeds in Phase 3 trial for Adcetris in new lymphoma condition